Participants taking EVOO experienced significant decreases in pain interference and severity, along with better emotional and physical functioning, indicating a potential breakthrough in trigeminal neuralgia management.
A high compliance rate in consuming the recommended 60 mL daily, alongside improvements in overall diet quality and safety profile of EVOO, highlights its feasibility and tolerability as a therapeutic intervention for trigeminal neuralgia.
Collection
[
|
...
]